Inclusion Criteria:  Adult women of reproductive age with confirmed diagnosis of PCOS (Rotterdam Criteria, including at least 2 of 3 characteristics: oligomenorrhea, clinical and/or biochemical hyperandrogenism and ultrasound criteria) No BMI restriction Able and willing to provide explicit, informed consent  Exclusion Criteria:  Type 1 diabetes, medication-controlled type 2 diabetes Pregnancy Currently participating in weight loss programme, or reported weight change in last 3 months (>5% of current body weight) Documented history of eating disorder Ovulation medication, such as clomiphene citrate Weight loss medication affecting weight or appetite in last 6 months, including weight loss medications, antipsychotic drugs or other medications as determine by the physician (eg. Semaglutide, liraglutide, orlistat, amphetamines, Qsymia (phentermine-topiramate), bupropion-naltrexone (Contrave)) Known liver, renal or thyroid dysfunction Unable to participate in follow-up for at least 24 weeks Unable or unwilling to provide explicit, informed consent